$4M US DOD grant to study sleep disturbances and Parkinson’s
The U.S. Department of Defense has granted $4 million in funding to support an investigation by U.S. researchers into the…
Articles by Margarida Maia, PhD
Parkinson’s often correctly diagnosed, but challenges remain
Despite an accuracy rate of 91% in diagnosing Parkinson’s disease, misdiagnoses still occur in the clinic, particularly with Lewy…
DaT scan may spot aspiration, pneumonia risk with Parkinson’s
A dopamine transporter scan — an exam that visualizes dopaminergic neurons, the nerve cells that are affected in…
A-dopamine pump extends on time for Parkinson’s patients
Parkinson’s disease patients saw an average increase of more than four hours in the duration of their symptom control,…
Vitamin biotin eases symptoms of parkinsonism in fruit flies: Study
Biotin (vitamin B7) supplementation may offer protection against manganese-induced brain cell damage, according to a recent study. Manganese is a…
Cell-based brain implants for Parkinson’s are in development
Researchers at the University of Cambridge in the U.K. are developing brain implants using small clusters of lab-grown cells in…
Ancient viral remnants in DNA may mark Parkinson’s, be protective
Levels of a retrovirus that entered the human genome via infections millions of years ago — an endogenous retrovirus called…
Aging microglia may offer therapeutic targets for Parkinson’s
Aging microglia, the immune cells of the brain that protect it by fighting infections and clearing debris, may mount a…
Study: Unusual sensations, paranoia common in Parkinson’s patients
Approximately two-thirds of Parkinson’s disease patients may experience paranoia and unusual sensations, including visual hallucinations, according to a new…
LRRK2 regulator ID’d as potential therapeutic target in Parkinson’s
U.S. researchers have identified, as a potential therapeutic target in Parkinson’s disease, a protein that controls part of the…